We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+22.62%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.77B
AUM Growth
+$282M
Cap. Flow
+$179M
Cap. Flow %
10.07%
Top 10 Hldgs %
30.07%
Holding
2,442
New
714
Increased
405
Reduced
476
Closed
723

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$43.9M
2
FDC
First Data Corporation
FDC
+$23.8M
3
ULTI
Ultimate Software Group Inc
ULTI
+$17.6M
4
CNC icon
Centene
CNC
+$16.8M
5
LXFT
Luxoft Holding, Inc.
LXFT
+$14.3M

Top Sells

Rank Stock Value
1
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
+$47.3M
2
SHPG
Shire pic
SHPG
+$43.4M
3
P
Pandora Media Inc
P
+$25.4M
4
IMPV
Imperva, Inc.
IMPV
+$19.5M
5
ATHN
Athenahealth, Inc.
ATHN
+$17.1M

Sector Composition

Rank Sector Weight
1 Technology 7.8%
2 Healthcare 6.74%
3 Communication Services 5.4%
4 Consumer Discretionary 5.34%
5 Real Estate 3.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHYD icon
1676
VanEck Short High Yield Muni ETF
SHYD
$456M
$2K ﹤0.01%
100
– –
VNDA icon
1677
CALL
Vanda Pharmaceuticals
VNDA
$302M
$2K ﹤0.01%
100
-100
-50% -$2.28K
VTRS icon
1678
Viatris
VTRS
$18.9B
$2K ﹤0.01%
88
-69,960
-100% -$2.04M
AE
1679
DELISTED
Adams Resources & Energy Inc
AE
$2K ﹤0.01%
49
-1,103
-96% -$44.4K
USAP
1680
DELISTED
Universal Stainless & Alloy
USAP
$2K ﹤0.01%
+100
New +$1.71K
ASXC
1681
CALL
DELISTED
Asensus Surgical, Inc.
ASXC
$2K ﹤0.01%
+77
New +$2.58K
DCPH
1682
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$2K ﹤0.01%
+76
New +$1.99K
IMGN
1683
CALL
DELISTED
Immunogen Inc
IMGN
$2K ﹤0.01%
+700
New +$3.03K
RAD
1684
CALL
DELISTED
Rite Aid Corporation
RAD
$2K ﹤0.01%
190
– –
TYME
1685
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$2K ﹤0.01%
882
-79,935
-99% -$209K
JAX
1686
DELISTED
J. Alexander's Holdings, Inc.
JAX
$2K ﹤0.01%
+200
New +$1.84K
UROV
1687
DELISTED
Urovant Sciences Ltd.
UROV
$2K ﹤0.01%
193
-26
-12% -$267
TNAV
1688
DELISTED
Telenav Inc.
TNAV
$2K ﹤0.01%
+300
New +$1.58K
PGNX
1689
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$2K ﹤0.01%
+504
New +$2.28K
TOWR
1690
DELISTED
Tower International, Inc.
TOWR
$2K ﹤0.01%
103
-7,179
-99% -$184K
ABEO icon
1691
Abeona Therapeutics
ABEO
$413M
$1K ﹤0.01%
5
-1
-17% -$179
COR icon
1692
Cencora
COR
$61.2B
$1K ﹤0.01%
13
-972
-99% -$78.1K
EB
1693
DELISTED
Eventbrite
EB
$1K ﹤0.01%
+69
New +$1.95K
CHRN
1694
ChronoScale Holdings
CHRN
$3.04B
$1K ﹤0.01%
1
– –
GNW icon
1695
CALL
Genworth Financial
GNW
$3.71B
$1K ﹤0.01%
+200
New +$876
MOMO
1696
Hello Group
MOMO
$866M
$1K ﹤0.01%
32
-27,051
-100% -$865K
IMDX
1697
Insight Molecular Diagnostics
IMDX
$156M
$1K ﹤0.01%
+16
New +$1.03K
ACH
1698
Accendra Health
ACH
$214M
$1K ﹤0.01%
252
-9,240
-97% -$58.4K
SGMO
1699
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1K ﹤0.01%
+100
New +$1.02K
SMHI icon
1700
SEACOR Marine Holdings
SMHI
$258M
$1K ﹤0.01%
100
-100
-50% -$1.34K
66 67
68
69 70

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Prelude Capital Management held 2,442 positions worth $1.77B, up 19% from $1.49B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Prelude Capital Management deployed $179M of net new capital in Q1 2019, opening 714 new positions and adding to 405 existing holdings. Its largest new stake was Ultimate Software Group Inc: 57,473 shares worth $19M.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, down from 12% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Integrated Device Technology I, an estimated $12.7M trimmed.

  • Prelude Capital Management's largest Q1 2019 buy was Ultimate Software Group Inc: 57,473 shares worth $19M.
  • Prelude Capital Management added most to Celgene Corp in Q1 2019, an estimated $43.9M increase.
  • Prelude Capital Management's biggest Q1 2019 reduction was Integrated Device Technology I, cutting an estimated $12.7M.
  • Prelude Capital Management fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $47.3M.
  • Prelude Capital Management's ten largest holdings make up 30% of its $1.77B portfolio in Q1 2019.
  • Prelude Capital Management opened 714 new positions and closed 723 in Q1 2019.
  • Prelude Capital Management's portfolio value rose 19% quarter-over-quarter to $1.77B.

Based on Prelude Capital Management's 13F filing for Q1 2019, filed 15 May 2019.